NewAmsterdam Pharma Ownership | Who Owns NewAmsterdam Pharma?
NewAmsterdam Pharma Ownership Summary
NewAmsterdam Pharma is owned by 11.17% institutional investors, 0.96% insiders, and 87.88% retail investors. Frazier life sciences management is the largest institutional shareholder, holding 14.81% of NAMS shares. American Funds SMALLCAP World A is the top mutual fund, with 7.30% of its assets in NewAmsterdam Pharma shares.
NAMS Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | NewAmsterdam Pharma | 11.17% | 0.96% | 87.88% |
| Sector | Healthcare Stocks | 35.58% | 11.87% | 52.55% |
| Industry | Biotech Stocks | 35.80% | 11.85% | 52.35% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Frazier life sciences management | 16.94M | 14.81% | $542.37M |
| Capital world investors | 11.11M | 9.71% | $355.60M |
| Ra capital management | 9.55M | 8.35% | $305.70M |
| Fcpm iii services b.v. | 9.20M | 8.04% | $294.46M |
| Fmr | 8.77M | 7.66% | $280.59M |
| Bain capital life sciences investors | 7.31M | 6.39% | $233.88M |
| Wellington management group llp | 5.12M | 4.47% | $163.76M |
| Deerfield management company, l.p. (series c) | 4.26M | 3.73% | $136.52M |
| Viking global investors lp | 4.20M | 3.67% | $134.56M |
| Duquesne family office | 3.07M | 2.68% | $98.28M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Fcpm iii services b.v. | 9.20M | 40.77% | $294.46M |
| Bain capital life sciences investors | 7.31M | 21.09% | $233.88M |
| Frazier life sciences management | 16.94M | 13.96% | $542.37M |
| Medicxi ventures management (jersey) | 2.67M | 8.72% | $85.60M |
| Artia global partners lp | 503.94K | 3.56% | $16.13M |
| Ra capital management | 9.55M | 3.24% | $305.70M |
| Duquesne family office | 3.07M | 2.91% | $98.28M |
| First turn management | 558.34K | 2.00% | $17.87M |
| Healthinvest partners ab | 94.80K | 1.78% | $5.51M |
| Deerfield management company, l.p. (series c) | 4.26M | 1.61% | $136.52M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Fmr | 8.77M | 0.01% | 2.35M |
| Westfield capital management co lp | 2.20M | 0.30% | 2.20M |
| Capital world investors | 11.11M | 0.05% | 1.13M |
| Bnp paribas asset management | 957.44K | 0.04% | 780.43K |
| Ameriprise financial | 753.05K | 0.01% | 600.78K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Siren | - | - | -765.71K |
| Pictet asset management sa | 6.53K | 0.00% | -739.59K |
| Jennison associates | 2.75M | 0.06% | -738.82K |
| Capital investors | 1.44M | 0.01% | -621.40K |
| First turn management | 558.34K | 2.00% | -335.14K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Westfield capital management co lp | 2.20M | 0.30% | 2.20M | $70.52M |
| Marshall wace, llp | 264.80K | 0.01% | 264.80K | $8.48M |
| Axa investment managers | 196.78K | 0.02% | 196.78K | $5.60M |
| Peregrine capital management | 178.49K | 0.21% | 178.49K | $5.71M |
| Victory capital management | 172.66K | 0.00% | 172.66K | $5.53M |
Sold Out
| Holder | Change |
|---|---|
| Kilter group | -9.00 |
| Gamma investing | -10.00 |
| Advisor group | -10.00 |
| Principal securities | -13.00 |
| Coldstream capital management | -24.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | 61 | -68.39% | 12,772,651 | -89.23% | 11 | 0.11% | 34 | -69.64% | 14 | -73.08% |
| Dec 31, 2025 | 55 | -62.07% | 12,251,519 | -89.84% | 10 | 0.09% | 32 | -58.44% | 10 | -72.97% |
| Sep 30, 2025 | 43 | -66.67% | 10,963,801 | -90.21% | 9 | 0.10% | 20 | -75.61% | 10 | -62.96% |
| Jun 30, 2025 | 135 | 3.05% | 116,309,195 | 16.74% | 103 | 1.40% | 85 | 11.84% | 28 | -9.68% |
| Mar 31, 2025 | 135 | -3.57% | 111,187,228 | 12.82% | 95 | 0.89% | 78 | -11.36% | 33 | 6.45% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| American Funds SMALLCAP World A | 8.40M | 7.30% | -200.00K |
| Vanguard Health Care Inv | 3.95M | 3.38% | 280.70K |
| Capital Group Global Equity Canada F | 2.52M | 2.16% | - |
| Strategic Advisers Fidelity US TtlStk | 1.78M | 1.55% | 316.00K |
| Polar Capital Biotech S Inc | 1.72M | 1.47% | -955.31K |
| Fidelity Contrafund | 1.27M | 1.10% | 77.77K |
| Jennison SMid Cap Core Equity | 966.54K | 0.84% | -119.37K |
| Capital Group New Economy Comp | 957.48K | 0.83% | 286.38K |
| American Funds New Economy A | 957.48K | 0.83% | 286.38K |
| AB Small Cap Growth A | 686.06K | 0.61% | 32.56K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| May 26, 2026 | Kooij Louise Frederika | Chief Accounting Officer | Sell | $2.32M |
| Mar 11, 2026 | LANGE LOUIS G | - | Sell | $1.34M |
| Mar 11, 2026 | LANGE LOUIS G | - | Sell | $13.93K |
| Mar 06, 2026 | LANGE LOUIS G | - | Sell | $828.95K |
| Mar 05, 2026 | Kastelein Johannes Jacob Pieter | Chief Scientific Officer | Sell | $3.17M |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q2 | - | 1 |
| 2026 Q1 | - | 31 |
| 2025 Q4 | - | 3 |
| 2025 Q3 | 3 | 10 |
| 2025 Q2 | 3 | 5 |
NAMS Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools